(Q33908977)

29 July 2017

0 references

1 reference

title

Lecithin for dementia and cognitive impairment (English)

1 reference

29 July 2017

0 references

cognitive dysfunction

1 reference

J P Higgins

1

1 reference

29 July 2017

L Flicker

series ordinal

2

1 reference

29 July 2017

J P T Higgins

series ordinal

1

0 references

language of work or name

English

0 references

publication date

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

29 July 2017

2003

0 references

2000

0 references

published in

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

3

0 references

4

0 references

page(s)

CD001015

1 reference

A predictor for side effects in patients with Alzheimer's disease treated with deferoxamine mesylate.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001015

Lecithin administration in Alzheimer dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001015

Alzheimer disease: lack of effect of lecithin treatment for 3 months.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001015

Reduction of cholesterol risk factors by lecithin in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001015

Lecithin and memory training in suspected Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001015

Lecithin does not affect EEG spectral analysis or P300 in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001015

Memory decline in the aged: treatment with lecithin and physostigmine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001015

Cholinergic enhancement and REM sleep latency in the aged: lecithin does not reproduce physostigmine effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001015

Lecithin: absence of neurophysiologic effect in Alzheimer's disease by EEG topography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001015

Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: a double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001015

Lethicin in the Treatment of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001015

Brief objective measures for the determination of mental status in the aged.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001015

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001015

A new scale for clinical assessment in geriatric populations: Sandoz Clinical Assessment--Geriatric (SCAG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001015

Multiple nutrients in the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001015

10.1002/14651858.CD001015

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference